Hypertension has been reported in 8-32% of HIV-infected individuals. Large interarm blood pressure differences (IABPD) may cause misclassification of blood pressure (BP) status. The objectives of this study were to determine the magnitude and factors associated with IABPD in HIV-infected women and uninfected controls. Using automated devices, two BP recordings were measured and averaged from each arm in Brooklyn enrollees of the Women's Interagency HIV Study. Absolute IABPD was calculated for each patient. Among 335 subjects, 238 were HIV infected and 97 were uninfected. Mean systolic and diastolic IABPD were 6 Ϯ 5 mm Hg and 4 Ϯ 3 mm Hg, respectively. Twenty-six percent of subjects had systolic IABPD Ͼ10 mm Hg and 6% had systolic IABPD Ͼ20 mm Hg. Fifteen percent of subjects had diastolic IABPD Ͼ10 mm Hg. Interarm BP differences were not associated with HIV serostatus, CD4 ϩ cell count, and use of highly active antiretroviral therapy. Systolic IABPD Ͼ20 mm Hg was associated with obesity (ORadj 5.37, 95% CI 1.47, 19.65), and LDL cholesterol above 160 (ORadj 9.12, 95% CI 2.53, 32.88). Right arm BP measurement resulted in 10% of subjects with high/uncontrolled BP. Bilateral arm BP measurement increased the yield to 15% (p Ͻ 0.001). In conclusion, systolic and diastolic IABPD are common and appear to be of clinically important magnitude. Systolic IABPD are related to cardiovascular risk factors but not to HIV-related factors. Bilateral BP determination is important to detect and manage hypertension as well as for accurate cardiovascular risk assessment.
Introduction

H
YPERTENSION IS A WELL-KNOWN RISK FACTOR for cardiovascular disease and is common in HIV-infected persons. The prevalence of hypertension in HIV-infected individuals has been reported to range from 8% to 32%. [1] [2] [3] [4] [5] [6] [7] [8] Among 17,170 HIV-infected individuals with normal baseline blood pressure (BP), the incidence of hypertension was found to be 72.1 per 1000 patient-years. 9 Moreover, antiretroviral therapy has been linked to the development of hypertension. [5] [6] [7] [8] [9] The detection of hypertension is dependent upon the accurate measurement of BP. Multiple studies have shown significant interarm BP differences (IABPD) in HIV-uninfected individuals. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Large IABPD are associated with various cardiovascular risk factors, the presence of peripheral arterial disease, coronary artery disease, and higher cardiovascular event rates. [26] [27] [28] Large IABPD may also cause misclassification of BP status. The objectives of this study were to determine the magnitude of IABPD and factors associated with IABPD in a cohort of HIV-infected women and their uninfected controls.
Materials and Methods
The Women's Interagency HIV Study (WIHS) is an ongoing longitudinal multicenter study of HIV infection in women. The WIHS protocols, procedures, and baseline results have been previously described. 29 Briefly, at six enrollment sites, women have been interviewed and examined at baseline and semiannual visits, and laboratory studies were performed at each visit. The current analysis includes crosssectional data from women examined at the Brooklyn site in New York City between June 21, 2004 and April 5, 2005 . The study was approved by the WIHS sites and by the Institutional Review Board of SUNY Downstate Medical Center, and all participants provided written informed consent. The WIHS semiannual follow-up visits include medical history and health behavior questionnaires and assessments of medication use, standardized clinical and laboratory measurements, and blood draws. Subjects were instructed to fast for at least 8 h prior to their blood draw. Laboratory values including glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), and triglycerides were measured at central laboratories. Low-density lipoprotein cholesterol (LDL-C) was estimated from the Friedewald equation. For specimens that were nonfasting, and for fasting specimens with triglyceride levels over 400 mg/dl, levels of LDL-C were measured directly. Diabetes was defined as fasting blood glucose Ն126 mg/dl or by either a self-reported diagnosis of diabetes or treatment with medications. 30 Dyslipidemia was defined as total cholesterol Ն240 mg/dl, triglycerides Ն150 mg/dl, HDL Յ40 mg/dl, or LDL Ն160 mg/dl. 31, 32 LDL thresholds of Ն130 mg/dl and Ն100 mg/dl were also assessed. 33 Hypertension was defined as either Ͼ140/90 mm Hg or current treatment for hypertension. Body mass index (BMI) was calculated in kg/m 2 based on measured weights and heights and was classified as underweight (Ͻ18.5), normal weight (18.5-24.9), overweight (25.0-29.9), and obese (Ն30.0). Due to small numbers of participants in the underweight category, for analysis, BMI Ͻ25 was collapsed into a lean/normal category.
We conducted a cross-sectional analysis of women from the Brooklyn site of the WIHS who underwent ankle-brachial index evaluations during visits 20-22. BP was measured by sphygomamometry with patients lying in the supine position. A DINAMAP 1846 SX automated oscillometric device (Critikon, Inc., Tampa, FL) was used to measure BPs. With the participant resting in the supine position, the cuff was placed around each of the upper extremities in random order using a contour wrapping technique. Two separate BP recordings were obtained and were averaged for each of the upper limbs. Measurements were averaged for each arm and the absolute difference was calculated for each patient.
The outcome measures were mean systolic and mean diastolic IABPD. Systolic IABPD Ͼ10 mm Hg, systolic IABPD Ͼ20 mm Hg, and diastolic IABPD Ͼ10 mm Hg were considered clinically significant. Systolic IABPD Ն20 mm Hg have been reported to be present in 3.5-23% of subjects, 18, 19, 26 whereas differences Ն10 mm Hg have been found in 3.4-20%. 22, [24] [25] [26] To determine the clinical importance of bilateral BP measurement, patients were classified as having normal or controlled BP (Ͻ140/90 mm Hg) or high or uncontrolled BP (Ն140/90 mm Hg) based upon single arm (right) and also bilateral determinations.
Statistical analysis
Mean and absolute interarm systolic and diastolic BP differences were calculated. Differences in mean IABPD were compared between groups using Student's t-tests and analysis of variance. Chi square tests and Fisher's exact test were used for comparison of frequencies of absolute systolic and diastolic IABPD of 20 mm Hg and 10 mm Hg, respectively. Multiple logistic regression analyses were performed using systolic IABPD Ͼ20 mm Hg as the dependent variable and HIV status, CD4 ϩ cell count, age, race, exposure category, current cigarette smoking, BMI, hypertension, diabetes, total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride levels as independent variables. All factors meeting the criterion of p ϭ 0.2 on univariate analysis were candidates for inclusion in the model. Factors with p Ͻ 0.05 were included in the final multivariate logistic regression model, and hypertension was retained in the model due to its clinical significance, although statistical significance was borderline. McNemar's test was used to compare the diagnostic yield of single vs. bilateral arm determination for the detection of high or uncontrolled BP. All statistical analyses were achieved using the Statistical Package for Social Sciences (SPSS) 11.0 software (SPSS Inc., Chicago, IL).
Results
Among 335 subjects who were evaluated, 238 were HIV infected and 97 were uninfected. Patient characteristics are shown in Table 1 . HIV-infected patients were older, more likely to have low HDL cholesterol and elevated triglyceride levels, and more likely to be on cholesterol lowering medications. For HIV-infected women, the median CD4 ϩ count was 475.5 (IQR 289.0-679.5), 60.4% were on HAART, and 37% had undetectable HIV RNA viral loads.
Mean differences in systolic and diastolic BPs were 6 Ϯ 5 mm Hg and 4 Ϯ 3 mm Hg, respectively. Twenty-six percent of subjects had systolic IABPD Ͼ10 mm Hg and 6% had SBP difference Ͼ20 mm Hg. Fifteen percent of subjects had a diastolic IABPD Ͼ10 mm Hg. Mean interarm differences in systolic and in diastolic BP by clinical factors are shown in LAZAR ET AL. 696 Table 2 . On univariate analysis, obesity, hypertension, elevated total cholesterol levels, and elevated LDL cholesterol levels were associated with a systolic IABPD Ͼ20 mm Hg. Older age (Ͼ55 years) was associated with a 2.87-fold increase in the odds of having systolic IABPD Ͼ20 mm Hg, which was not statistically significant. On multivariate analysis, factors associated with a systolic IABPD Ͼ20 mm Hg were obesity and elevated LDL (Table 3) . HIV serostatus, race, and diabetes were not associated with systolic IABPD. Using only right arm BP measurement, 10% of subjects were found to have high/uncontrolled BP (Ն140/90 mm Hg). Bilateral arm measurement increased the yield to15% (p Ͻ 0.001), which results in one extra case detected for every 20 patients evaluated with bilateral instead of single arm determination.
Discussion
This study found mean interarm differences in systolic and diastolic BPs of 6 Ϯ 5 mm Hg and 4 Ϯ 3 mm Hg, respectively, in HIV-infected women and controls. Clinically significant differences were common as 26% of subjects had a systolic IABPD Ͼ10 mm Hg, 6% had systolic IABPD Ͼ20 mm Hg, and 15% of subjects had a diastolic IABPD Ͼ10 mm Hg. HIV- related factors such as HIV serostatus, CD4 ϩ cell count, and use of antiretroviral therapy were not associated with either systolic or diastolic IABPDs. The growing concern over cardiovascular disease in HIVinfected individuals has led to multiple studies examining the associations between HIV infection, antiretroviral therapy, and atherosclerosis. In addition to cardiovascular disease, hypertension is also a well-known risk factor for cerebrovascular disease and congestive heart failure, conditions that have also been linked to HIV infection. 33 Hypertension is common in HIV-infected individuals and is associated with both HIV-related and non-HIV-related risk factors. There is a continuum or risk between BP levels and cardiovascular event rates. 34 The accurate measurement of BP is important to establish the correct BP status, define baseline cardiovascular risk, and determine the effects of risk factor modifications.
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Prior studies of hypertension in the setting of HIV infection have relied upon single arm sphygmomamometric determination. [1] [2] [3] [4] [5] [6] [7] [8] [9] Accordingly, the significance of bilateral arm measurement has not been previously evaluated in this patient population. Absolute IABPD in the present study are similar to those reported in some earlier studies 28 but higher than in other studies. 19 Such differences are important in terms of defining cardiovascular risk as intervention trials have shown that small BP declines can result in large reductions in cardiovascular risk. 35 In the current study, systolic IABPD was associated with higher body mass index, hypertension, hypercholesterolemia, and elevated LDL. These findings are consistent with prior studies showing larger IABPD associated with various cardiovascular risk factors including hypertension, hyperlipidemia, diabetes, and obesity. 19, 25, 28 The trend toward an association of IABPD with age has also been observed previously. 19 Prior studies have found that higher IABPD is associated with peripheral arterial disease, coronary artery disease, 26, 28 and a higher risk of subsequent cardiovascular events. 27 Although the mechanism of IABPD remains unexplained, differences in waveform reflection due to increased arterial stiffness and arterial lumen narrowing are potential mechanisms. Arterial calcification is unlikely to play a major role in IABPD given the young age of the women studied. Whether women are more prone than men to high IABPD because of lower lean mass and smaller vessel size is unknown. Women in the study and control groups were ethnically diverse. Nearly 75% were AfricanAmerican and a 20% were Hispanic. The reclassification of BP status using bilateral arm measurement of patients would suggest that the prevalence of hypertension in HIV-infected individuals has been underestimated.
This study is subject to the inherent limitations of a crosssectional study. Thus we could not determine causality of IABPD, only associated factors. BPs were determined by an automated device. This technique has been validated and used in numerous epidemiologic studies in the assessment of cardiovascular risk and in the determination of IABPD. 15, 19, 24, 25 BPs were taken in the supine position. Although JNC guidelines recommend that BP be taken in the sitting position, 36 the supine position was used for several reasons. Prior studies evaluating IABPD have utilized the supine position, particularly in hospitalized patients. This method is consistent with WHO guidelines, which advocate a sitting or supine position. 37 In addition, the arms were more readily positioned at the level of the right atrium in the supine position. Arm positioning has been found to influence BP more markedly than body position. 38 Moreover, because both bilateral BP determinations were made in the same position, this would not be expected to affect the results. Prior studies have found systolic BP to be the same to 2 mm Hg lower and diastolic BP 2 mm Hg higher upon sitting as compared to lying supine. 39 The interarm BP difference was expressed as the absolute difference and not relative difference (right arm minus left arm or left arm minus right arm). Although higher BP is typically observed in the right as compared to the left arm, laterality of higher BP has not been considered clinically important. Although hand dominance was not recorded, IABPD was previously found to be unrelated to handedness. 17, 19, 20 Despite these limitations, we determined that systolic and diastolic IABPD commonly exist among HIV-infected and -uninfected women and appear to be clinically important. IABPD are related to cardiovascular risk factors but not to HIV-related factors. Bilateral BP determination results in reclassification of BP status from normal to high/uncontrolled in one of every 20 subjects evaluated. These results highlight the importance of bilateral BP determination for the detection and management of hypertension as well as accurate cardiovascular risk assessment. Further studies are needed to determine the prognostic value of abnormally high IABPD values in this patient population. Data regarding longitudinal changes in IABPD are lacking.
